Trichoderma Harzianum
Generic Name: trichoderma harzianum
Brand Names:
Trichoderma Harzianum
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: TRICHODERMA HARZIANUM (20000 [PNU]/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: TRICHODERMA HARZIANUM (20000 [PNU]/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Eucalyptus Globulus, Lung (bovine), Sanguinaria Canadensis, Adrenalinum, Belladonna
eucalyptus globulus, lung (bovine), sanguinaria canadensis, adrenalinum, belladonna
alpha-Adrenergic Agonist [EPC]
PURPOSE: Adrenalinum – Miner Breathing Issues, Excess Mucus and Lung Support,† Belladonna – Minor Breathing Issues and Lung Support,† Eucalyptus Globulus - Miner Breathing Issues, Excess Mucus and Lung Support,† Lung – Lung Support,† Sanguinaria Canadensis – Minor Breathing Issues, Cough and Lung Support.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Thymus (bovine), Thyroidinum (bovine), Parathyroid Gland (bovine)
thymus (bovine), thyroidinum (bovine), parathyroid gland (bovine)
PURPOSE: Provides specific sarcode support for the thyroid, thymus and parathyroid.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Ledipasvir And Sofosbuvir
ledipasvir and sofosbuvir
Hepatitis C Virus NS5A Inhibitor [EPC]
11 DESCRIPTION Ledipasvir and sofosbuvir tablets (90 mg/400 mg) are fixed-dose combination tablets containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.